Search bioRxivSearch

bioRxiv · 10.1101/666396

The effects of a 10-day partial sleep deprivation and the following recovery on cognitive functioning - a behavioural and EEG study.

Abstract

Sleep deprivation is an important societal problem that affects millions of people around the world on a daily basis. Our study aimed to examine the impact of a partial sleep restriction and following recovery processes on cognitive information processing, as evaluated by the Stroop test. We tested 15 participants over a period of 21 consecutive days, divided into 3 sleep conditions: 4 days of typical daily routine (baseline, base), 10 days of partial sleep deprivation ( SD), and 7 days of recovery ( rec). Each day, participants took part in an EEG experiment in which they performed a Stroop test, lasting for about 30 minutes, that required them to make an appropriate response to congruent and incongruent stimuli. Additionally, every day they answered a number of questions regarding their subjective levels of sleepiness and mood. During the whole period of 21 days, participants spontaneous locomotor activity was measured with the use of actigraphy. We have found behavioural and neural changes associated with different sleep conditions, such that the 10-day period of partial sleep restriction was linked with poorer behavioural performance on the Stroop test and an attenuated P300 neural response, compared to the baseline, followed by the observation of slow and gradual return in the period of recovery. This study, the first longitudinal study of its kind, shows that partial sleep deprivation has detrimental, long-term consequences on both behavioural and neural levels. This adds to the growing body of literature on this important issue in modern societies.\n\nSummarySleep deprivation, a world-wide problem in the 21st century, is associated with a number of complications, such as motor vehicle accidents (Lyznicki et al., 1998; Goel et al., 2009), medical errors (Barger et al., 2006), poorer health (in Colten & Altevogt, 2006), as well as cognitive deficits including problems with working memory and attention (van Dongen et al., 2003; Lim & Dinges, 2008). While total sleep deprivation (that is, a complete lack of sleep in a 24-hour period) is usually reserved only to certain professions (such as medical doctors), partial sleep restriction (that is, reducing ones sleep time in a 24-hour period to fewer hours than typically required) is world-wide and affects a large proportion of the population across the globe. Taking this global impact into account, and thus increasing our understanding of the neurophysiological and cognitive processes that are linked with partial sleep deprivation, could largely inform the public discussion over what kind of impact, if any, restricting our sleep has on our daily functioning. This 21-day long EEG study investigated the effects of a prolonged (10-day) sleep restriction, and the recovery processes (over a 7-day period) that followed. Each day participants performed a Stroop test, known to measure attentional levels, and completed a number of sleep-related questionnaires. We have found that while behavioural responses are easier to recover, the neurophysiological responses are heavily affected after a period of sleep deprivation, with one week of recovery being insufficient to return to a pre-testing performance of an individual.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Beres, A. M., Domagalik, A., Ochab, J. K., Oles, K., Oginska, H., Fafrowicz, M., Marek, T., Gudowska-Nowak, E., Nowak, M. M., Chialvo, D., Szwed, J.. 2019-06-11. The effects of a 10-day partial sleep deprivation and the following recovery on cognitive functioning - a behavioural and EEG study.. https://doi.org/10.1101/666396

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience